Abcuro
Updated: November 14, 2025
Founder Stefano Gullà
Country: USA | Funding: $414.8M (+)
Founded: 2015
Website: https://www.abcuro.com/
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.
Founded: 2015
Website: https://www.abcuro.com/
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.
